QNTM

ARW

Technologylarge cap
QNTM SCORE
55/100
MODERATE CONVICTION
top 19% of the universe

As of 2026-09-10, ARW scores 55out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. ARW trades at $213.44, 24% below the band floor.

ARW scores 55 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 55. Its strongest factor is value at 93 (exceptional), where it screens cheap on the model's valuation inputs, followed by sentiment at 61. The weakest is volume at 50, where volume gives little confirmation. Among Technology stocks it ranks in roughly the top 19% of the Technology names the model scores.

On valuation, ARW is priced near the floor of its own recent range — the cheap end on the model's valuation read. The blended composite before the macro overlay was 63. Same-sector names the model rates nearby include SNDK, HPQ, GEN.

This is a descriptive factor read on ARW, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where ARW sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum57
Quality53
Value93
Volume50
Sentiment61

VALUATION RANGE

QNTM’s descriptive fair-value band for ARW runs $282.30–$422.19. Current price $213.44 sits 24% below the band floor. This is valuation context, not a price target.

ARW APPEARS IN

Top Value
See ARW update live, and set an alert when its conviction changes

QNTM rescores ARW and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER TECHNOLOGY NAMES

SNDK59HPQ59GEN59NSIT58CRM58MU57RNG57GDDY57

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.